Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agrima Mian

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Transplantation and Cellular Therapy|August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid LeukemiaSanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.
Critical Care Medicine|December 30, 2025
Six-Year Trends in ICU Admission, Management, and Outcomes of Chimeric Antigen Receptor T-Cell Patients in the ICUPrabalini Rajendram, R Scott Stephens, Anne Rain T Brown, et al.
Critical Care Medicine|July 14, 2021
Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter StudyCristina Gutierrez, Anne Rain T Brown, Heather P May, et al.
Blood Cancer Journal|November 7, 2024
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphomaRossana Di Staso, Beatrice Casadei, Frederick L Locke, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 5, 2026
Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF TrialRonak H Mistry, Karine Tawagi, Daniel J Hausrath, et al.
JCO Oncology Practice|May 31, 2025
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF TrialVivek G Patel, Karine Tawagi, Samantha A Armstrong, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Blood Advances|July 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Transplantation and Cellular Therapy|August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid LeukemiaSanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.
Critical Care Medicine|December 30, 2025
Six-Year Trends in ICU Admission, Management, and Outcomes of Chimeric Antigen Receptor T-Cell Patients in the ICUPrabalini Rajendram, R Scott Stephens, Anne Rain T Brown, et al.
Critical Care Medicine|July 14, 2021
Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter StudyCristina Gutierrez, Anne Rain T Brown, Heather P May, et al.
Blood Cancer Journal|November 7, 2024
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphomaRossana Di Staso, Beatrice Casadei, Frederick L Locke, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 5, 2026
Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF TrialRonak H Mistry, Karine Tawagi, Daniel J Hausrath, et al.
JCO Oncology Practice|May 31, 2025
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF TrialVivek G Patel, Karine Tawagi, Samantha A Armstrong, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Blood Advances|July 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, et al.
Pageof 4